Summit Investment Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
3,420
-979
-22% -$79K 0.07% 77
2026
Q1
$381K Buy
4,399
+8
+0.2% +$766 0.14% 49
2025
Q4
$422K Buy
4,391
+1,100
+33% +$107K 0.16% 46
2025
Q3
$313K Sell
3,291
-189
-5% -$17.4K 0.12% 54
2025
Q2
$303K Buy
3,480
+252
+8% +$21.4K 0.13% 51
2025
Q1
$290K Buy
+3,228
New +$289K 0.14% 53
2024
Q4
Sell
-3,871
Closed -$348K 73
2024
Q3
$348K Buy
+3,871
New +$326K 0.18% 45
2024
Q2
Sell
-5,348
Closed -$466K 75
2024
Q1
$466K Buy
5,348
+776
+17% +$66.2K 0.28% 41
2023
Q4
$377K Buy
4,572
+1,444
+46% +$110K 0.24% 43
2023
Q3
$245K Buy
+3,128
New +$262K 0.18% 46

Other funds holding MDT

Summit Investment Advisory Services's MDT Position: Q2 2026 in Review

Summit Investment Advisory Services reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $79K and leaving 3,420 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #77.

Summit Investment Advisory Services first reported a position in MDT in Q3 2023 and has held it in 10 quarters since. The position peaked at $466K in Q1 2024. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Summit Investment Advisory Services held 3,420 shares of Medtronic worth $268K as of Q2 2026.
  • Summit Investment Advisory Services sold 979 Medtronic shares in Q2 2026, an estimated $79K.
  • Medtronic made up 0.07% of Summit Investment Advisory Services's portfolio in Q2 2026, its #77 holding.
  • Summit Investment Advisory Services first reported a position in Medtronic in Q3 2023 and has held it in 10 quarters since.
  • Summit Investment Advisory Services's Medtronic position peaked at $466K in Q1 2024.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Summit Investment Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.